The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Robin Bot Miller

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Robin Bot Miller is a private equity based in New York across 63 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Robin Bot Miller on Proptech.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Robin Bot Miller — Private Equity
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Robin Bot Miller — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Robin Bot Miller — 63
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Robin Bot Miller — Proptech

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Robin Bot-Miller — Private Equity · New York · 63 tracked deals · Robin Bot Miller portfolio

Similar investors

• Thomas S. Giannetti
• Pete Mathias
• Tom Newby
• Magnus Grimeland
• Thomas Teles
• Antler Special Opportunities GP I LLC
• Lexington Partners GP Holdings X, L.L.C.
• Christopher Walsh
• Daniel Fabian
• Steven G. Glenn

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Robin Bot Miller · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory